These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 5531642

  • 1. [Preventive effect of beta-glucuronidase inhibitor (SLA) on recurrence of the bladder tumor].
    Miyagawa M, Harada T, Yoshida O, Kato T.
    Hinyokika Kiyo; 1970 Dec; 16(12):738-44. PubMed ID: 5531642
    [No Abstract] [Full Text] [Related]

  • 2. [Diacetyl-glucaro-(1 leads to 4) (6 leads to 3)-dilactone (SLA) for prevention of bladder tumor recurrence].
    Shiraishi T, Nihira H.
    Hinyokika Kiyo; 1970 Oct; 16(10):586-92. PubMed ID: 5529995
    [No Abstract] [Full Text] [Related]

  • 3. [A study of prophylaxis for recurrence of bladder tumor. Some statistical and experimental studies on the long term administration of -glucuronidase inhibitor (2,5-di-o-acetyl, D-glucaro(1-4)(6-3) dilactone) to patients of bladder tumor].
    Katayama Y.
    Nihon Hinyokika Gakkai Zasshi; 1972 Nov; 63(11):951-71. PubMed ID: 4675186
    [No Abstract] [Full Text] [Related]

  • 4. The effect of urinary -glucuronidase inhibition on the induction of bladder tumors with 2-acetylaminofluorene in rats.
    Miyakawa M, Yoshida O, Harada T, Kato T.
    Invest Urol; 1973 Jan; 10(4):256-61. PubMed ID: 4683376
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical application of glucarolactone to bladder tumor. II. Effect of SLA on recurrence of bladder tumor].
    Yonese Y.
    Nihon Hinyokika Gakkai Zasshi; 1970 Oct; 61(10):995-1003. PubMed ID: 5529307
    [No Abstract] [Full Text] [Related]

  • 6. [The effect of added dietary beta-glucuronidase inhibitor on the occurrence of 2-acetyl-aminofluorene induced bladder tumors in rats].
    Miyakawa M.
    Hinyokika Kiyo; 1970 Nov; 16(11):653-69. PubMed ID: 5530618
    [No Abstract] [Full Text] [Related]

  • 7. [Problems of recurrence of bladder tumor].
    Niijima T.
    Nihon Ishikai Zasshi; 1971 Sep; 66(5):497-502. PubMed ID: 5165600
    [No Abstract] [Full Text] [Related]

  • 8. [Tumor recurrence prevention using photodynamic therapy after treatment of bladder cancer].
    Sun X, Li H, Wang M.
    Zhonghua Wai Ke Za Zhi; 1995 Mar; 33(3):179-80. PubMed ID: 7555391
    [Abstract] [Full Text] [Related]

  • 9. Clinical application of 2,5-DI-O-acetyl- -D-gluca ro- (1-4) (6-3)-dilactone (SLA) to the bladder tumor, with special reference to its effect on frequency of tumor recurrences.
    Ichikawa T.
    J Urol; 1972 Oct; 108(4):571-6. PubMed ID: 4654258
    [No Abstract] [Full Text] [Related]

  • 10. [The immunotherapy of bladder tumors and the immunoprophylaxis of disease recurrence].
    Korovin AI, Savvin VT.
    Urol Nefrol (Mosk); 1996 Oct; (1):19-21. PubMed ID: 8659034
    [Abstract] [Full Text] [Related]

  • 11. Adriamycin instillations as recurrence prophylaxis in superficial urinary bladder cancer.
    Jauhiainen K, Alfthan O.
    Ann Chir Gynaecol; 1984 Oct; 73(4):206-10. PubMed ID: 6508201
    [Abstract] [Full Text] [Related]

  • 12. [Beta-glucuronidase in carcinoma of the bladder and effects of its inhibitor].
    Shiraishi T.
    Hinyokika Kiyo; 1969 Mar; 15(3):143-70. PubMed ID: 5814572
    [No Abstract] [Full Text] [Related]

  • 13. [Control of bladder tumors. Transabdominal ultrasonic scanning versus cystoscopy].
    Graversen HP, Sørensen LH.
    Ugeskr Laeger; 1987 Nov 23; 149(48):3253-5. PubMed ID: 3324434
    [No Abstract] [Full Text] [Related]

  • 14. [Studies on urinary beta-glucuronidase in patients with bladder cancer].
    Tamiya T.
    Sapporo Igaku Zasshi; 1966 Nov 23; 29(5):269-303. PubMed ID: 5338305
    [No Abstract] [Full Text] [Related]

  • 15. Intravesical thiotepa in prevention of recurrence of bladder tumour.
    Ghosal SK, Sen DK.
    J Indian Med Assoc; 1980 Nov 01; 75(9):173-4. PubMed ID: 6785360
    [No Abstract] [Full Text] [Related]

  • 16. [A new way of preventing urinary bladder tumors].
    Pliss GB, Vlasov NN.
    Vopr Onkol; 1996 Nov 01; 42(2):68-73. PubMed ID: 8815637
    [Abstract] [Full Text] [Related]

  • 17. Fluid intake and the risk of tumor recurrence in patients with superficial bladder cancer.
    Donat SM, Bayuga S, Herr HW, Berwick M.
    J Urol; 2003 Nov 01; 170(5):1777-80. PubMed ID: 14532774
    [Abstract] [Full Text] [Related]

  • 18. [Intravesical BCG therapy for superficial bladder cancer].
    Segawa N, Iwamoto Y, Azuma H, Yamamoto K, Ueda H, Katsuoka Y.
    Hinyokika Kiyo; 1998 Sep 01; 44(9):627-31. PubMed ID: 9805666
    [Abstract] [Full Text] [Related]

  • 19. [The prevention of recurrences of surface bladder cancer by BCG vaccinal immunotherapy].
    Matveev BP, Kariakin OB, Safiullin KN, Figurin KM, Levi DT, Vatin OE.
    Urol Nefrol (Mosk); 1993 Sep 01; (5):27-9. PubMed ID: 8310581
    [No Abstract] [Full Text] [Related]

  • 20. [Our experience with mitomycin C in the prophylaxis of superficial bladder tumors; retrospective study].
    Moyano Calvo JL, Herrero Torres L, Melón Rey FJ, Rabadán Ruiz M, Pereira Sanz I.
    Arch Esp Urol; 1994 Oct 01; 47(8):750-4. PubMed ID: 7818293
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.